Hongyang Lu

1.4k total citations · 2 hit papers
84 papers, 888 citations indexed

About

Hongyang Lu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Hongyang Lu has authored 84 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Oncology, 41 papers in Pulmonary and Respiratory Medicine and 22 papers in Epidemiology. Recurrent topics in Hongyang Lu's work include Lung Cancer Research Studies (48 papers), Lung Cancer Treatments and Mutations (30 papers) and Neuroendocrine Tumor Research Advances (22 papers). Hongyang Lu is often cited by papers focused on Lung Cancer Research Studies (48 papers), Lung Cancer Treatments and Mutations (30 papers) and Neuroendocrine Tumor Research Advances (22 papers). Hongyang Lu collaborates with scholars based in China, Poland and United States. Hongyang Lu's co-authors include Chenghui Li, Fajun Xie, Jing Qin, Jing Qin, Na Han, Ying Fan, Zhiyu Huang, Huang Jie, Cheng‐Hui Li and Zhiming Jiang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Hongyang Lu

80 papers receiving 875 citations

Hit Papers

H2S‐Releasing Versatile Montmorillonite Nanoformulation T... 2024 2026 2025 2024 2025 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongyang Lu China 18 453 375 242 171 106 84 888
Yanqiu Zhao China 18 472 1.0× 434 1.2× 387 1.6× 81 0.5× 194 1.8× 102 1.1k
Alberto D’Angelo United Kingdom 18 449 1.0× 382 1.0× 348 1.4× 66 0.4× 188 1.8× 59 1000
Motoki Yoshida Japan 14 335 0.7× 511 1.4× 112 0.5× 86 0.5× 97 0.9× 34 956
Zhenxiang Li China 18 477 1.1× 281 0.7× 320 1.3× 87 0.5× 226 2.1× 72 962
Meiqi Shi China 16 448 1.0× 393 1.0× 559 2.3× 92 0.5× 364 3.4× 70 1.0k
B. F. El-Rayes United States 19 615 1.4× 385 1.0× 348 1.4× 105 0.6× 220 2.1× 38 1.2k
Yubo Wang China 14 200 0.4× 172 0.5× 350 1.4× 135 0.8× 75 0.7× 70 965
Hong-Yun Zhao China 13 394 0.9× 220 0.6× 321 1.3× 38 0.2× 82 0.8× 21 775

Countries citing papers authored by Hongyang Lu

Since Specialization
Citations

This map shows the geographic impact of Hongyang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyang Lu more than expected).

Fields of papers citing papers by Hongyang Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongyang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyang Lu. The network helps show where Hongyang Lu may publish in the future.

Co-authorship network of co-authors of Hongyang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongyang Lu. A scholar is included among the top collaborators of Hongyang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongyang Lu. Hongyang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Hongyang, Qiang Zhou, Li Yu, et al.. (2025). CO‐Releasing Polyoxometalates Nanozyme with Gut Mucosal Immunity and Microbiota Homeostasis Remodeling Effects for Restoring Intestinal Barrier Integrity. Advanced Science. 12(17). e2500116–e2500116. 6 indexed citations
4.
Jie, Huang, Hongyang Lu, & Yajun Huang. (2024). Spatial Dynamic Interaction Effects and Formation Mechanisms of Air Pollution in the Central Plains Urban Agglomeration in China. Atmosphere. 15(8). 984–984. 1 indexed citations
5.
Hu, Shumin, et al.. (2024). Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets. Therapeutic Advances in Medical Oncology. 16. 12684029–12684029. 3 indexed citations
6.
Jie, Huang, Hongyang Lu, Huali Jin, & Long Zhang. (2023). Urban resilience in China’s eight urban agglomerations: evolution trends and driving factors. Environmental Science and Pollution Research. 32(6). 3072–3098. 3 indexed citations
8.
Chen, Jing, Meihui Li, & Hongyang Lu. (2023). Nuclear protein in testis carcinoma of the lung. Translational Oncology. 30. 101640–101640. 3 indexed citations
9.
Li, Chenghui, et al.. (2020). EGFR exon 20 insertion mutations in non-small cell lung cancer. Translational Cancer Research. 9(4). 2982–2991. 16 indexed citations
10.
Wang, Zeng, Zhiming Jiang, & Hongyang Lu. (2019). Molecular genetic profiling of small cell lung carcinoma in a Chinese cohort. Translational Cancer Research. 8(1). 255–261. 2 indexed citations
11.
Lei, Lei, Zhiming Jiang, Cheng‐Hui Li, & Hongyang Lu. (2019). KRAS Exon 3 and PTEN Exon 7 Mutations in Small-cell Lung Cancer. Current Medical Science. 39(3). 379–384. 1 indexed citations
12.
Lu, Hongyang, Xiaoling Tong, Fajun Xie, et al.. (2018). Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma. BMC Cancer. 18(1). 251–251. 20 indexed citations
13.
Fan, Yun, Zhiyu Huang, Yanjun Xu, et al.. (2018). P1.12-01 A Single-Arm Multi-Center Phase II Study of Apatinib in Patients with ES-SCLC After Second/Third-Line Chemotherapy. Journal of Thoracic Oncology. 13(10). S573–S573. 2 indexed citations
14.
Lei, Lei, et al.. (2018). MGMT promoter methylation and 1p/19q co-deletion of surgically resected pulmonary carcinoid and large-cell neuroendocrine carcinoma. World Journal of Surgical Oncology. 16(1). 110–110. 7 indexed citations
15.
Li, Chenghui & Hongyang Lu. (2018). Adenosquamous carcinoma of the lung. OncoTargets and Therapy. Volume 11. 4829–4835. 58 indexed citations
16.
Fan, Yun, Xuehua Zhu, Yan Xu, et al.. (2017). Cell-Cycle and DNA-Damage Response Pathway Is Involved in Leptomeningeal Metastasis of Non–Small Cell Lung Cancer. Clinical Cancer Research. 24(1). 209–216. 45 indexed citations
17.
Fan, Yun, Min Hu, Xuehua Zhu, et al.. (2017). OA08.01 Exploration of the Underlying Mechanisms of Leptomeningeal Metastasis in NSCLC Patients through NGS of Cerebrospinal Fluid. Journal of Thoracic Oncology. 12(1). S271–S271. 3 indexed citations
18.
Fan, Yun, Lei Gong, Hongyang Lu, et al.. (2017). P3.02b-079 Effects of Icotinib with and without Radiation Therapy on Patients with EGFR Mutant Non-Small Cell Lung Cancer and Brain Metastases. Journal of Thoracic Oncology. 12(1). S1238–S1238. 1 indexed citations
19.
Xie, Fajun, Hongyang Lu, Qin Jin, et al.. (2016). The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis. OncoTargets and Therapy. 9. 171–171. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026